Nisa Investment Advisors, LLC Gossamer Bio, Inc. Transaction History

Nisa Investment Advisors, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 07, 2022	BUY	$7.21 - $14.88 $389 - $803	54 New	54 $1,000
Q2 2022 Aug 03, 2022	SELL	$5.97 - $9.97 $420,347 - $701,987	-70,410 Closed	0 $0
Q1 2022 Apr 29, 2022	BUY	$8.44 - $12.49 $339,288 - $502,098	40,200 Added 133.07%	70,410 $611,000
Q4 2021 Feb 03, 2022	BUY	$10.12 - $14.07 $237,415 - $330,082	23,460 Added 347.56%	30,210 $290,000
Q3 2021 Oct 18, 2021	SELL	$7.25 - $13.23 $253,750 - $463,050	-35,000 Reduced 83.83%	6,750 $85,000
Q2 2021 Aug 06, 2021	BUY	$8.0 - $9.75 $334,000 - $407,062	41,750 New	41,750 $339,000

109

167M

430K

519K

Ticker GOSS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 93,954,000
Market Cap $84.6M
Description
Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology in the United States. The company is developing GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colony...

Get notified when there are updates to the investment portfolio of Nisa Investment Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Nisa Investment Advisors, LLC with notifications on news.